Sanofi S.p.A

Form 483 issued February 2, 2023 · Anagni, Italy

Inspection
Jan 30 – Feb 2, 2023
Observations
2
Pages
5
FEI number
3002807108

In short: On February 2, 2023, FDA issued a Form 483 with 2 observations to Sanofi S.p.A in Anagni, Frosinone (FEI 3002807108) after an inspection that ran Jan 30 – Feb 2, 2023. The investigator was Joshua J. Silvestri. Most observations concern cAPA; the most-cited regulation is 21 CFR 820.100 (corrective and preventive action).

At a glance

2 of 2 observations on this 483 concern capa.

CAPA2

Most cited: 21 CFR 820.100 (1×) · 820.198 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Procedures for corrective and preventive action have…

  2. 02

    Procedures for receiving, reviewing, and evaluating complaints by a formally designated unit have…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Sanofi S.p.A?

FDA listed 2 observations on this Form 483, mostly about cAPA. The most-cited regulation is 21 CFR 820.100 (corrective and preventive action). The opening words of each observation are shown on this page.

Who inspected Sanofi S.p.A?

Joshua J. Silvestri is named on this Form 483, for the inspection of Jan 30 – Feb 2, 2023. Each investigator has a profile showing what they cite most.

When was Sanofi S.p.A inspected by FDA?

The inspection ran Jan 30 – Feb 2, 2023, and the Form 483 is dated February 2, 2023.

How do I get the full Form 483 for Sanofi S.p.A?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free